ALAvery Love

Avery Love

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Avery Love has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Afaq Motiwala

    Department of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA

    1 shared publication
  • Aiham Albaeni

    Department of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA

    1 shared publication
  • Alexander Bosley

    Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

    1 shared publication
  • Chandler O'LEary

    Center for Phage Technology, Texas A&M University, College Station, Texas, USA

    1 shared publication
  • Khalil Anouti

    Department of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA

    1 shared publication
  • Peter Rasmussen

    Department of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA

    1 shared publication

Latest Publications

  • Open Access

    Non-ST-Segment Elevation Myocardial Infarction Secondary to Embolic Prosthetic Valve Thrombus

    by Avery Love, Alexander Bosley, Peter Rasmussen, Ramy Abdelmaseih, Khalil Anouti, Afaq Motiwala, Aiham Albaeni

  • Open Access

    Coronary Artery Supply to a Cardiac Mass

    by Avery Love, Steven Mai, Rizwan Khan

  • Open Access

    Coronary Revascularization in the Era of TAVR: Timing, Strategy, and Outcomes

    by Avery Love, Chandler O’leary, Shahman Shahab

    Background: Coronary artery disease (CAD) is prevalent among patients undergoing transcatheter aortic valve replacement (TAVR), complicating clinical decision-making regarding optimal timing of percutaneous coronary intervention (PCI). Despite widespread clinical experience, there is ongoing controversy and limited consensus regarding when PCI, before, during, or after TAVR, offers the best risk-benefit balance. Objective: To synthesize and critically evaluate the current evidence on different PCI timing strategies in patients undergoing TAVR and to identify areas of uncertainty and clinical complexity. Review: Randomized trials, including ACTIVATION and NOTION-3, have yielded mixed findings, highlighting a modest reduction in ischemic events with pre-TAVR PCI but increased procedural bleeding risks. Observational registries (REVASC-TAVI and the National Readmissions Database) have similarly shown that pre- and peri-TAVR PCI strategies carry heightened risks of complications without clear long-term mortality benefits. Recent meta-analyses reinforce these findings, indicating that no PCI timing strategy conclusively outperforms others in reducing long-term mortality. Key considerations such as anatomical complexity, frailty, bleeding risk, and valve type significantly influence optimal PCI timing. Conclusion: Current evidence supports a personalized, patient-centered approach to PCI timing in TAVR candidates, emphasizing careful consideration of individual anatomical and clinical factors rather than a standardized timing protocol. Further research exploring advanced risk stratification, imaging modalities, and long-term clinical outcomes is essential to refine current guidelines and practice.